dna-diagnostics-logo
covid 19 test kit main shdw

Zero Contact ™ - The First FDA EUA Authorized At-Home Saliva
COVID-19 Test

$135
-
+

The First FDA EUA Authorized
At-Home Saliva COVID-19 Test

Our self-collected COVI-19 testing kit uses a hassle-free saliva sample to determine if you are infected with the SARS-CoV-2 virus. Our partner lab RUCDR Infinite Biologics is operating under the Emergency Use Authorization guidelines issued by the FDA. Our COVID-19 home saliva test kits include shipping to your home and back to the lab. Within 72 hours of the lab receiving your sample, you will receive secure digital results.

Collection Method:
Saliva Collection Tube

Digital Results Available Within:
72 hours of the lab receiving the sample

How It Works:

Step 1- Order Test Kits

Step 1: Order Test Kits

Place an order to have a test kit sent directly to you.

Step 2- Employees Register Test Kits

Step 2: Register Your Kit

Once you received your kit in the mail, you must register it at 1health.io/register.

Step 3- Employees Collect Samples

Step 3: Collect Sample

After registering your kit, carefully follow the onscreen instructions and proceed to collect your saliva in the provided tube. Then return your sample using the mail carrier you selected.

Step 4- Receive Your Results

Step 4: Await Results

Results will be made available within 72 hours of the lab receiving your sample. Please view your results immediately and follow the recommendations given.

FDA Authorization

This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.